[Federal Register Volume 89, Number 104 (Wednesday, May 29, 2024)]
[Notices]
[Page 46420]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-11746]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1357]


Bulk Manufacturer of Controlled Substances Application: Pharmaron 
Manufacturing Services (US) LLC; Correction

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Drug Enforcement Administration (DEA) published a document 
in the Federal Register on May 6, 2024, concerning an application for a 
Bulk Manufacturer of Controlled Substances. A request was made for the 
removal of the following information: ``The company plans to bulk 
manufacture the listed controlled substances for the purpose of 
producing material for clinical trials.'' Please correct notice to read 
as follows as stated under Supplementary Information.

SUPPLEMENTARY INFORMATION:

Correction

    In the Federal Register on May 6, 2024, in FR Doc. 2024-09805, (89 
FR 37260), 37260-37261 (2 pages). The purpose is to manufacture bulk 
noroxymorphone as an intermediate product to be sold to a customer who 
will indicate a Contract Manufacturer Organization (CMO), which the 
material will be shipped to, to be converted to a non-controlled 
substance. Oxymorphone (9652) will be used as a starting material to be 
converted to Noroxymorphone (9668).
    No other activities for these drug codes are authorized for this 
registration.

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Oxymorphone.............................    9652  II
Noroxymorphone..........................    9668  II
------------------------------------------------------------------------


Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-11746 Filed 5-28-24; 8:45 am]
BILLING CODE 4410-09-P